The overall mortality rate of patients with SSc was higher than that of the general population, probably because of poor prognostic factors including organ involvement. These factors should be carefully monitored during followup. Atsushi Hashimoto. The Journal of Rheumatology. July 15, 2011. (Also see: Prognosis and Mortality)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.